Power Law company profile

VectorBuilder

Biotech & Life Sciences · Chicago, United States · Founded 2014 Unicorn

Offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

6 investors on VectorBuilder's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage

Xiamen C&D

Legend Capital

Suikai Investment

Wanlian Securities

Guangzhou Industrial Investment Fund

Yuexiu Industrial Fund

Global footprint

Where VectorBuilder has talent and traffic

Workforce by country

14 countries with
team presence

🇺🇸 United States29%

🇬🇧 United Kingdom21.5%

🇨🇳 China12%

🇦🇷 Argentina9.2%

🇩🇪 Germany8.6%

Top 5 of 14 shown

Web traffic by country

150K monthly visits
across markets

🇺🇸 United States35.5%

🇬🇧 United Kingdom6.5%

🇮🇳 India6%

🇹🇼 Taiwan4.6%

🏳️ Korea4.4%

Top 5 markets shown

Market sentiment

What the market is saying about VectorBuilder

An AI-synthesized read of the highest-engagement posts about VectorBuilder on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See VectorBuilder on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles